Tag Archives: Cognitive Impairment in Parkinson’s Disease (CIND-PD)

Issues in the Clinical Diagnosis of Dementia with Lewy Bodies (Translational Neurodegeneration)

Summary This article discusses recent progress, and problems remaining, in the clinical diagnosis of Dementia with Lewy Bodies (DLB). The sensitivity of accurate clinical diagnosis of DLB is said to be low. It seems likely that it may be possible … Continue reading

Posted in Diagnosis, For Doctors (mostly), For Researchers (mostly), International, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Cholinesterase Inhibitors for Dementia with Lewy Bodies, Parkinson’s Disease Dementia and Cognitive Impairment in Parkinson’s Disease (Cochrane Library)

[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 2 Issue 9, April 2012]. Summary Earlier Cochrane reviews have examined the use of cholinesterase inhibitors in both Parkinson’s Disease with dementia (PDD) and dementia with … Continue reading

Posted in Acute Hospitals, Community Care, For Doctors (mostly), For Researchers (mostly), Pharmacological Treatments, Systematic Reviews, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment